ITGB2 and neoplasm: Also, the two tumor lines used in the Jaiswal study (SW1990 and CD18/HPAF) were different from ones used in our present work (Capan-1, HPAF-II, and BxPC3) and no control MUC4-negative cell line was analyzed.